StockWatch
·
Medical/Dental Instruments
Quarterly ResultAug 12, 2026, 07:32 AM

BrainsWay Q2 Revenue +35% to $17.1M; Raises FY26 Guidance

AI Summary

BrainsWay Ltd. reported strong second-quarter 2026 financial results, with revenue increasing 35% to $17.1 million and Adjusted EBITDA more than doubling to $3.5 million. The company also saw significant operational growth, shipping a record 125 Deep TMS systems and growing remaining performance obligations to $80.4 million. Due to this strong momentum, BrainsWay has raised its full-year 2026 revenue and Adjusted EBITDA guidance.

Key Highlights

  • Q2 2026 revenue increased 35% to $17.1 million.
  • Adjusted EBITDA more than doubled to $3.5 million, with a 20% margin.
  • Remaining performance obligations grew 30% year-over-year to $80.4 million.
  • Shipped a record 125 Deep TMS systems in Q2 2026, a 42% increase.
  • Operating income rose over 300% to $2.4 million, with a 14% margin.
  • Net income increased 34% to $2.7 million.
  • Generated $6.3 million in cash flow from operations during Q2 2026.
  • Raises FY 2026 revenue guidance to $68M-$70M and Adjusted EBITDA to $13M-$14M.